Cargando…
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289743/ https://www.ncbi.nlm.nih.gov/pubmed/32535148 http://dx.doi.org/10.1016/j.cmi.2020.06.006 |
_version_ | 1783545519935586304 |
---|---|
author | Rovida, F. Cereda, D. Novati, S. Licari, A. Triarico, A. Marseglia, G.L. Bruno, R. Baldanti, F. |
author_facet | Rovida, F. Cereda, D. Novati, S. Licari, A. Triarico, A. Marseglia, G.L. Bruno, R. Baldanti, F. |
author_sort | Rovida, F. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7289743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72897432020-06-12 Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy Rovida, F. Cereda, D. Novati, S. Licari, A. Triarico, A. Marseglia, G.L. Bruno, R. Baldanti, F. Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2020-11 2020-06-12 /pmc/articles/PMC7289743/ /pubmed/32535148 http://dx.doi.org/10.1016/j.cmi.2020.06.006 Text en © 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Rovida, F. Cereda, D. Novati, S. Licari, A. Triarico, A. Marseglia, G.L. Bruno, R. Baldanti, F. Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy |
title | Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy |
title_full | Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy |
title_fullStr | Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy |
title_full_unstemmed | Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy |
title_short | Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy |
title_sort | low risk for sars-cov2 symptomatic infection and early complications in paediatric patients during the ongoing covid19 epidemics in lombardy |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289743/ https://www.ncbi.nlm.nih.gov/pubmed/32535148 http://dx.doi.org/10.1016/j.cmi.2020.06.006 |
work_keys_str_mv | AT rovidaf lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy AT ceredad lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy AT novatis lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy AT licaria lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy AT triaricoa lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy AT marsegliagl lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy AT brunor lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy AT baldantif lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy AT lowriskforsarscov2symptomaticinfectionandearlycomplicationsinpaediatricpatientsduringtheongoingcovid19epidemicsinlombardy |